tradingkey.logo

Electromed Inc

ELMD
View Detailed Chart
29.110USD
+0.110+0.38%
Close 02/06, 16:00ETQuotes delayed by 15 min
243.27MMarket Cap
29.82P/E TTM

Electromed Inc

29.110
+0.110+0.38%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.38%

5 Days

-2.54%

1 Month

+2.54%

6 Months

+57.95%

Year to Date

-0.03%

1 Year

-15.13%

View Detailed Chart

TradingKey Stock Score of Electromed Inc

Currency: USD Updated: 2026-02-06

Key Insights

Electromed Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 59 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 36.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Electromed Inc's Score

Industry at a Glance

Industry Ranking
59 / 205
Overall Ranking
165 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Electromed Inc Highlights

StrengthsRisks
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 33.15% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 64.00M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 64.00M.
Fairly Valued
The company’s latest PE is 29.82, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.36M shares, decreasing 0.04% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 447.28K shares of this stock.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
36.000
Target Price
+24.14%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Electromed Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Electromed Inc Info

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Ticker SymbolELMD
CompanyElectromed Inc
CEOCunniff (James L)
Websitehttps://smartvest.com/
KeyAI